Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe PneumoniaOlivier Hermine, Robin Charreteur, Joseph Emmerich et al.|JAMA Internal Medicine|2020Cited by 777
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trialPierre‐Louis Tharaux, Robin Charreteur, Gilles Pialoux et al.|The Lancet Respiratory Medicine|2021Cited by 297
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patientsA. Mékinian, Corrado Campochiaro, Lucie Biard et al.|Lara D. Veeken|2021Cited by 59
Prognosis and long‐term outcomes in type I cryoglobulinemia: A multicenter study of 168 patientsAmine Ghembaza, Gonçalo Boleto, Marin Bommelaer et al.|American Journal of Hematology|2023Cited by 17
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective studyA. Mékinian, Francesco Muratore, Lucie Biard et al.|RMD Open|2023Cited by 12